GHSR and Prader-Willi syndrome: Despite this, the direct approach of treating PWS patients with a GHSR1a antagonist, to our knowledge, has not been tested; this is likely because early clinical studies where GHSR1a antagonists were tested as antiobesity agents in normal subjects proved disappointing.